Karyopharm Therapeutics reported $-83079000 in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Abbott ABT:US $ 35399M 403M
Abbvie ABBV:US $ 16283M 875M
Amgen AMGN:US $ 916M 5784M
AstraZeneca AZN:LN 36340M 2928M
Astrazeneca AZN:US $ 36340M 2928M
Avrobio Inc AVRO:US $ 143.16M 26.31M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Eli Lilly And LLY:US $ 9330.8M 351.6M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
Epizyme EPZM:US $ 11.12M 31.81M
GlaxoSmithKline GSK:LN 16181M 1126M
Johnson & Johnson JNJ:US $ 74709M 686M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Macrogenics MGNX:US $ 178.21M 61.4M
Merk MRK:US $ 40883M 2699M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Novartis NVS:US $ 61540M 6115M
Novartis NOVN:VX SF 61540M 6115M
Pfizer PFE:US $ 82424M 5224M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Takeda 4502:JP Y 5683019M 351690M
Tg Therapeutics TGTX:US $ 170.39M 66.77M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Xencor XNCR:US $ 763.02M 29.52M
YTE INCY:US $ 3863.07M 93.07M